Breaking News
December 14, 2017 - Living Lyme disease bacteria found months after antibiotic treatment
December 14, 2017 - These annual checkups help seniors not only survive but thrive
December 14, 2017 - Study reveals impact of diabetes during pregnancy on baby’s heart
December 14, 2017 - Huntington’s disease drug clears initial hurdles
December 14, 2017 - TPU researchers create 3D-printed models of children’s hearts
December 14, 2017 - Brain responses of children with inherited dyslexia risk predict their future reading speed
December 14, 2017 - Study: New Furosemide Formulation Simplifies Administration for HF
December 14, 2017 - Discrimination harms your health—and your partner’s
December 14, 2017 - Having older brothers may increase the likelihood of being gay
December 14, 2017 - New scientific yardstick released to help early detection of Alzheimer’s disease
December 14, 2017 - New finding demonstrates what happens at cellular level during onset of type2 diabetes
December 14, 2017 - Study identifies potassium as key to circadian rhythms in red blood cells
December 14, 2017 - Good friends might be your best brain booster as you age
December 14, 2017 - NIH expected to award up to $70 million to launch Alzheimer’s Clinical Trials Consortium
December 14, 2017 - Pitting pathogens against each other could prevent drug resistance emerging
December 14, 2017 - Study provides new insights into development of Sonic Hedgehog medulloblastoma
December 14, 2017 - Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis
December 14, 2017 - Gene Screens Can Alter Perception, Behavior
December 14, 2017 - Can Scrotal Vein Condition Hike Heart Risks?: MedlinePlus Health News
December 14, 2017 - Molecules in spit may be able to diagnose and predict length of concussions
December 14, 2017 - Children’s Colorado and RxRevu partner to help prescribers better meet needs of pediatric patients
December 14, 2017 - Researchers discover new way to attack drug-resistant prostate cancer cells
December 14, 2017 - Scientists develop new, high resolution method for identifying microbial species and strains
December 14, 2017 - Declining trend of salmonellosis cases has leveled off in the EU
December 14, 2017 - Death receptors in the blood can help measure risk of cardiovascular diseases, type 2 diabetes
December 14, 2017 - How to Perk Up the Holidays for Hospital Patients
December 14, 2017 - Prolonged Sedation May be Bad for Baby’s Brain
December 14, 2017 - The pediatric submersion score predicts children at low risk for injury following submersions
December 14, 2017 - Video game helps doctors to quickly recognize trauma patients who need high levels of care
December 14, 2017 - Younger persons newly-diagnosed with type 2 diabetes have poorer health than older patients
December 14, 2017 - Clinician re-examines evidence on re-use of catheters and UTIs in people with spinal cord injuries
December 14, 2017 - UK and Russian researchers join forces against AMR
December 14, 2017 - Results of Bariatric Surgery Hold Up Over Time
December 14, 2017 - High-intensity exercise delays Parkinson’s progression
December 14, 2017 - Protein structure could pave way for effective drugs to treat cystic fibrosis
December 14, 2017 - Minority people less likely to see dermatologist for psoriasis treatment
December 14, 2017 - Study indicates decline in use of chemotherapy for early stage breast cancer patients
December 14, 2017 - Chagas disease presents real public health problem to Canadians
December 14, 2017 - Experts call for rigorous clinical trials in use of experimental fetal therapy
December 14, 2017 - Lactic acid bacteria can offer protection against subtypes of influenza A virus
December 14, 2017 - Tapeworm drug could provide new hope for patients with Parkinson’s disease
December 14, 2017 - Parkinson’s progression delayed through high-intensity exercise, study says
December 14, 2017 - Researchers discover potential regulator essential for killer T cells to reside in tumors
December 14, 2017 - Tailor-made protein combats several kinds of pathogenic bacteria
December 14, 2017 - Hidden genes hold blueprints for designing new anti-cancer drugs
December 14, 2017 - Male virgins still at risk for acquiring HPV, study finds
December 14, 2017 - Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia
December 14, 2017 - Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer
December 14, 2017 - AHA: Hospital QI Initiative Fails to Budge Outcomes in India
December 14, 2017 - Scientists observe tremors associated with Parkinson’s disease in fruit flies
December 14, 2017 - Newly discovered molecular chaperones may soon be part of therapies for Huntington’s disease
December 14, 2017 - Performing surgery on virtual patient could provide valuable insight into consequences
December 13, 2017 - New insights into mosquito sex protein could provide strategies to control diseases
December 13, 2017 - Lilly’s Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
December 13, 2017 - Step Into Sunshine | Medpage Today
December 13, 2017 - Poor Prognosis for Diabetic Foot Sores: MedlinePlus Health News
December 13, 2017 - Exercise alone does not lead to weight loss in women—in the medium term
December 13, 2017 - Researchers use new approach to identify casual mechanisms in depression
December 13, 2017 - Genetic Analysis and Bio-Rad enter into supply and distribution agreement for GA-map clinical test
December 13, 2017 - Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups
December 13, 2017 - Scientists discover how axons in developing visual system stabilize their connections
December 13, 2017 - Novel compound inhibits mycomembrane biosynthesis and kills tuberculosis bacteria
December 13, 2017 - FDA Launches New Tool for Sharing Information That Allows Doctors to Better Manage Antibiotic Use
December 13, 2017 - Evolocumab Wins FDA Approval for Stand-Alone CVD Prevention
December 13, 2017 - Powerful Clot-Busting Drugs Not Useful After Leg Blockages: Study: MedlinePlus Health News
December 13, 2017 - The fight against obesity: To tax or not to tax?
December 13, 2017 - Isolation during holidays can impact health of seniors
December 13, 2017 - Specialized physiotherapy provides many benefits for patients with Parkinson’s disease
December 13, 2017 - Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia
December 13, 2017 - Researchers find link between brain structure and hallucination proneness, musical aptitude
December 13, 2017 - Radiation responsive molecules derived from horse chestnuts aid cancer imaging
December 13, 2017 - New Gene Therapy May Be Cure for ‘Bubble Boy’ Disease
December 13, 2017 - MorningBreak: Insurance Driving Drug Prices? Crunch Time for ACA; The ‘Other’ Drug Problem
December 13, 2017 - Are Stents Really Useless After Chest Pain? Cardiologists Not Sure: MedlinePlus Health News
December 13, 2017 - Can you train yourself to develop ‘super senses’?
December 13, 2017 - Cellular self-digestion process plays role in development of autoimmune diseases
December 13, 2017 - E-cigarette use among youth leads to smoking as adults finds study
December 13, 2017 - New nanomaterial could enable new types of chemical processes in pharma, materials and chemical industries
December 13, 2017 - Another CGRP Drug Gains Ground in Migraine
December 13, 2017 - Trigger for most common form of vision loss discovered
NIH grant supports research on cellular mechanisms governing longevity

NIH grant supports research on cellular mechanisms governing longevity

image_pdfDownload PDFimage_print

The MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging (NIA), one of the institutes of the National Institutes of Health, for research on the cellular mechanisms governing longevity.

The grant will allow Rogers to delve more deeply into his discovery that NMD (nonsense-medicated decay), a regulatory mechanism that governs a wide array of genetic functions, also plays a critical role in extending longevity under conditions of dietary restriction (DR).

DR, which typically involves a dramatic reduction in calories without malnutrition, has been known for many years to extend lifespan and delay or reduce the risk of many age-related diseases in a wide range of species, from single-celled yeasts to primates.

“We have found that the restriction and redirection of NMD has a major influence on the extension of lifespan under conditions of DR,” Rogers said. “The takeaway is that the NMD pathway is a requirement for the increase in longevity that occurs with DR; if it doesn’t work properly, lifespan extension is forfeited.”

The role of DR in prolonging healthy lifespan has set scientists on a quest to identify drug candidates called “DR mimetics” that mimic the effects of DR on longevity. The use of such drugs would allow patients to experience the health- and lifespan-enhancing effects of DR without the difficulty of adhering to a diet that drastically cuts calories.

The significance of Rogers’ discovery lies with the fact that the pharmaceutical industry is already intensely focused on developing drugs to manipulate NMD because of its role in many genetic disorders and many forms of cancer. Rogers’ discovery thus raises the possibility that these drugs could be repurposed to extend healthy lifespan.

“The fact that NMD is already a target for therapeutic manipulation is good news,” Rogers said. “Since drug candidates vary in their targets, effectiveness and the speed with which they move through the development process, an expanded pipeline increases the likelihood that life-extending therapies will soon become available.”

In the classical model, NMD functions as a quality control mechanism by removing aberrant gene products that could result in the production of deleterious proteins. However, mutations can cause NMD to inappropriately target certain proteins, resulting in cancers and genetic disorders such as cystic fibrosis and hemophilia.

Rogers’ data suggest a revised model in which NMD functions like a control panel that helps an organism adapt to environmental stressors such as food scarcity by changing gene activity levels. Thus, drugs that target NMD could be used to trigger the adaptive responses normally associated with DR, bypassing the need for extreme dieting.

Since big pharma is already developing drugs that inhibit or redirect NMD for use in the treatment of genetic disorders, Rogers’ discovery raises the possibility that some of these drugs could offer a “new realm” of DR mimetics.

“The identification of NMD’s role in longevity opens the door to the development of new therapies to prolong lifespan,” said Kevin Strange, Ph.D., MDI Biological Laboratory president. “This grant from the National Institutes of Health will help expedite Dr. Rogers’ important research on elucidating the genetic pathways of aging.”

Rogers works at the Kathryn W. Davis Center for Regenerative Biology and Medicine, where he studies aging in C. elegans, a nematode worm that is a popular model in aging research because it shares nearly half its genes with humans and because its short lifespan allows scientists to quickly assess the role of anti-aging interventions.

Source:

https://mdibl.org/press-release/mdi-biological-laboratory-scientist-receives-grant-to-study-aging/

Tagged with:

About author

Related Articles